Please use this identifier to cite or link to this item:
https://doi.org/10.32598/bcn.11.covid19.1
DC Field | Value | |
---|---|---|
dc.title | COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper | |
dc.contributor.author | Farhoudian, A. | |
dc.contributor.author | Baldacchino, A. | |
dc.contributor.author | Clark, N. | |
dc.contributor.author | Gerra, G. | |
dc.contributor.author | Ekhtiari, H. | |
dc.contributor.author | Dom, G. | |
dc.contributor.author | Mokri, A. | |
dc.contributor.author | Sadeghi, M. | |
dc.contributor.author | Nematollahi, P. | |
dc.contributor.author | Demasi, M. | |
dc.contributor.author | Schutz, C.G. | |
dc.contributor.author | Hashemian, S.M. | |
dc.contributor.author | Tabarsi, P. | |
dc.contributor.author | Galea-Singer, S. | |
dc.contributor.author | Carra, G. | |
dc.contributor.author | Clausen, T. | |
dc.contributor.author | Kouimtsidis, C. | |
dc.contributor.author | Tolomeo, S. | |
dc.contributor.author | Radfar, S.R. | |
dc.contributor.author | Razaghi, E.M. | |
dc.date.accessioned | 2021-08-19T04:30:46Z | |
dc.date.available | 2021-08-19T04:30:46Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Farhoudian, A., Baldacchino, A., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schutz, C.G., Hashemian, S.M., Tabarsi, P., Galea-Singer, S., Carra, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S.R., Razaghi, E.M. (2020). COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper. Basic and Clinical Neuroscience 11 (2) : 133-150. ScholarBank@NUS Repository. https://doi.org/10.32598/bcn.11.covid19.1 | |
dc.identifier.issn | 2008-126X | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/197938 | |
dc.description.abstract | Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD). © 2020 Iran University of Medical Sciences. All rights reserved. | |
dc.publisher | Iran University of Medical Sciences | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | Scopus OA2020 | |
dc.subject | Addiction medicine | |
dc.subject | Coronavirus | |
dc.subject | Coronavirus Disease 2019 (COVID-19) | |
dc.subject | Harm reduction | |
dc.subject | Methadone | |
dc.subject | Opioid substitution therapy | |
dc.subject | Pandemic | |
dc.subject | Policy | |
dc.subject | Public health | |
dc.subject | Substance use disorder | |
dc.type | Review | |
dc.contributor.department | DEAN'S OFFICE (ARTS & SOCIAL SC.) | |
dc.description.doi | 10.32598/bcn.11.covid19.1 | |
dc.description.sourcetitle | Basic and Clinical Neuroscience | |
dc.description.volume | 11 | |
dc.description.issue | 2 | |
dc.description.page | 133-150 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_32598_bcn_11_covid19_1.pdf | 1.12 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License